Home > Insider Trading > Filing (0001209191-13-051362)

Filing Details

Accession Number:: 0001209191-13-051362
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-11-08 14:39:47
Reporting Period:: 2013-11-06

Filing Date:: 2013-11-08
Accepted Time:: 2013-11-08 14:39:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1443669	Proto Labs Inc	PRLB	Fabricated Structural Metal Products (3440)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1542472	A. Bradley Cleveland	5540 Pioneer Creek Drive Maple Plain MN 55359	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-11-06	19,811	$84.01	232,121	No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
Common Stock	Disposition	2013-11-06	12,577	$85.51	219,544	No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
Common Stock	Disposition	2013-11-06	14,450	$85.86	205,094	No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
Common Stock	Disposition	2013-11-06	1,831	$87.32	203,263	No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
Common Stock	Disposition	2013-11-07	38,040	$79.00	165,223	No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
Common Stock	Disposition	2013-11-07	25,141	$80.32	140,082	No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
Common Stock	Disposition	2013-11-07	10,857	$81.01	129,225	No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
Common Stock	Disposition	2013-11-07	5,898	$82.24	123,327	No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
Common Stock	Disposition	2013-11-07	3,056	$83.35	120,271	No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
Common Stock	Disposition	2013-11-07	2,903	$84.65	117,368	No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust

Footnotes

Sales effected pursuant to Rule 10b5-1 trading plan adopted by the Bradley A. Cleveland Declaration Trust (the "Trust") on August 30, 2013.
Reflects the weighted average price of 19,811 shares of common stock of Proto Labs, Inc. sold by the Trust in multiple transactions on November 6, 2013 with sale prices ranging from $83.58 to $84.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Reflects the weighted average price of 12,577 shares of common stock of Proto Labs, Inc. sold by the Trust in multiple transactions on November 6, 2013 with sale prices ranging from $84.79 to $85.78 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Reflects the weighted average price of 14,450 shares of common stock of Proto Labs, Inc. sold by the Trust in multiple transactions on November 6, 2013 with sale prices ranging from $85.785 to $86.19 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Reflects the weighted average price of 1,831 shares of common stock of Proto Labs, Inc. sold by the Trust in multiple transactions on November 6, 2013 with sale prices ranging from $86.98 to $87.68 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Reflects the weighted average price of 38,040 shares of common stock of Proto Labs, Inc. sold by the Trust in multiple transactions on November 7, 2013 with sale prices ranging from $78.64 to $79.53 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Reflects the weighted average price of 25,141 shares of common stock of Proto Labs, Inc. sold by the Trust in multiple transactions on November 7, 2013 with sale prices ranging from $79.76 to $80.74 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Reflects the weighted average price of 10,857 shares of common stock of Proto Labs, Inc. sold by the Trust in multiple transactions on November 7, 2013 with sale prices ranging from $80.77 to $81.66 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Reflects the weighted average price of 5,898 shares of common stock of Proto Labs, Inc. sold by the Trust in multiple transactions on November 7, 2013 with sale prices ranging from $81.81 to $82.60 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Reflects the weighted average price of 3,056 shares of common stock of Proto Labs, Inc. sold by the Trust in multiple transactions on November 7, 2013 with sale prices ranging from $83.21 to $83.81 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Reflects the weighted average price of 2,903 shares of common stock of Proto Labs, Inc. sold by the Trust in multiple transactions on November 7, 2013 with sale prices ranging from $84.37 to $85.125 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.